Cardioprotective effects of arjunolic acid in LPS-stimulated H9C2 and C2C12 myotubes via the MyD88-dependent TLR4 signaling pathway

References

• Al-Gayyar MM, Al Youssef A, Sherif IO, Shams ME, Abbas A. 2014. Protective effects of arjunolic acid against cardiac toxicity induced by oral sodium nitrite: effects on cytokine balance and apoptosis. Life Sci. 111(1–2):18–26. doi: 10.1016/j.lfs.2014.07.002.
   PubMed Web of Science ®Google Scholar
• Bakar MHA, Tan JS. 2017. Improvement of mitochondrial function by celastrol in palmitate treated C2C12 myotubes via activation of PI3K-AKT signaling pathway. Biomed Pharmacother. 93:903–912. doi: 10.1016/j.biopha.2017.07.021.
   PubMed Web of Science ®Google Scholar
• Bansal T, Chatterjee E, Singh J, Ray A, Kundu B, Thankamani V, Sengupta S, Sarkar S. 2017. Arjunolic acid, a peroxisome proliferator-activated receptor agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling. J Biol Chem. 292(40):16440–16462. doi: 10.1074/jbc.M117.788299.
   PubMed Web of Science ®Google Scholar
• Beiter T, Hudemann J, Burgstahler C, Nieß AM, Munz B. 2018. Effects of extracellular orotic acid on acute contraction-induced adaptation patterns in C2C12 cells. Mol Cell Biochem. 448(1-2):251–263. doi: 10.1007/s11010-018-3330-z.
   PubMed Web of Science ®Google Scholar
• Bode AM, Dong Z. 2007. The functional contrariety of JNK. Mol Carcinog. 46(8):591–598. doi: 10.1002/mc.20348.
   PubMed Web of Science ®Google Scholar
• Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA, Lizasoain I. 2007. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation. 115(12):1599–1608. doi: 10.1161/CIRCULATIONAHA.106.603431.
   PubMed Web of Science ®Google Scholar
• Chao W. 2009. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol. 296(1):H1–12. doi: 10.1152/ajpheart.00995.2008.
   PubMed Web of Science ®Google Scholar
• Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, Yada M, Pohlman TH, Verrier ED. 2004. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg. 128(2):170–179. doi: 10.1016/j.jtcvs.2003.11.036.
   PubMed Web of Science ®Google Scholar
• Elsawy H, Almalki M, Elmenshawy O, Abdel-Moneim A. 2022. In vivo evaluation of the protective effects of arjunolic acid against lipopolysaccharide-induced septic myocardial injury. Peer J. 10:12986.
   Web of Science ®Google Scholar
• Fan X, Zhang Y, Dong H, Wang B, Ji H, Liu X. 2015. Trilobatin attenuates the LPS-mediated inflammatory response by suppressing the NF-κB signaling pathway. Food Chem. 166:609–615. doi: 10.1016/j.foodchem.2014.06.022.
   PubMed Web of Science ®Google Scholar
• Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, Kelly RA. 1999. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 104(3):271–280. doi: 10.1172/JCI6709.
   PubMed Web of Science ®Google Scholar
• Frost RA, Nystrom GJ, Lang CH. 2004. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C2C12 myoblasts via toll-like receptor-4 and C-Jun nh2-terminal kinase pathways. Am J Physiol Cell Physiol. 287(6):C1605–C1615. doi: 10.1152/ajpcell.00010.2004.
   PubMed Web of Science ®Google Scholar
• Ghosh J, Das J, Manna P, Sil PC. 2011. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis. Biomaterials. 32(21):4857–4866. doi: 10.1016/j.biomaterials.2011.03.048.
   PubMed Web of Science ®Google Scholar
• Gilde AJ, der Lee KAV, Willemsen PH, Chinetti G, der Leij FRV, der Vusse GJV, Staels B, Bilsen MV. 2003. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res. 92(5):518–524. doi: 10.1161/01.RES.0000060700.55247.7C.
   PubMed Web of Science ®Google Scholar
• Hazarika L, Sen S, Doshi J. 2021. Molecular docking analysis of arjunolic acid from Terminalia arjuna with a coronary artery disease target APOE4. Bioinformation. 17(11):949–958. doi: 10.6026/97320630017949.
   PubMed Web of Science ®Google Scholar
• Hemalatha T, Pulavendran S, Balachandran C, Manohar BM, Puvanakrishnan R. 2010. Arjunolic acid: a novel phytomedicine with multifunctional therapeutic applications. Indian J Exp Biol. 48:238–247.
   PubMed Web of Science ®Google Scholar
• Ikebe M, Kitaura Y, Nakamura M, Tanaka H, Yamasaki A, Nagai S, Wada J, Yanai K, Koga K, Sato N, et al. 2009. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TRL4/MyD88 signaling pathway. J Surg Oncol. 100(8):725–731. doi: 10.1002/jso.21392.
   PubMed Web of Science ®Google Scholar
• Kalyanavenkataraman S, Nanjan P, Banerji A, Nair BG, Kumar GB. 2016. Discovery of arjunolic acid as a novel non-zinc binding carbonic anhydrase II inhibitor. Bioorg Chem. 66:72–79. doi: 10.1016/j.bioorg.2016.03.009.
   PubMed Web of Science ®Google Scholar
• Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. 1999. Unresponsiveness of myd88-deficient mice to endotoxin. Immunity. 11(1):115–122. doi: 10.1016/s1074-7613(00)80086-2.
   PubMed Web of Science ®Google Scholar
• Knuefermann P, Sakata Y, Baker JS, Huang CH, Sekiguchi K, Hardarson HS, Takeuchi O, Akira S, Vallejo JG. 2004. Toll-like receptor 2 mediates staphylococcus aureus-induced myocardial dysfunction and cytokine production in the heart. Circulation. 110(24):3693–3698. doi: 10.1161/01.CIR.0000143081.13042.04.
   PubMed Web of Science ®Google Scholar
• Li H, Li Y, Liu D, Liu J. 2014. LPS promotes epithelial–mesenchymal transition and activation of TKR4/JNK signaling. Tumour Biol. 35(10):10429–10435. doi: 10.1007/s13277-014-2347-5.
   PubMed Web of Science ®Google Scholar
• Manna P, Sil PC. 2012. Impaired redox signaling and mitochondrial uncoupling contributes vascular inflammation and cardiac dysfunction in type 1 diabetes: protective role of arjunolic acid. Biochimie. 94(3):786–797. doi: 10.1016/j.biochi.2011.11.010.
   PubMed Web of Science ®Google Scholar
• Manna P, Sinha M, Sil PC. 2008. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch Toxicol. 82(3):137–149. doi: 10.1007/s00204-007-0272-8.
   PubMed Web of Science ®Google Scholar
• Meng Z, Yan C, Deng Q, Gao DF, Niu XL. 2013. Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol Sin. 34(7):901–911. doi: 10.1038/aps.2013.24.
   PubMed Web of Science ®Google Scholar
• Miriyala S, Chandra M, Maxey B, Day A, Clair DKS, Panchatcharam M. 2015. Arjunolic acid ameliorates reactive oxygen species via inhibition of p47phox-serine phosphorylation and mitochondrial dysfunction. Int J Biochem Cell Biol. 68:70–77. doi: 10.1016/j.biocel.2015.08.015.
   PubMed Web of Science ®Google Scholar
• Mishra S, Chatterjee S. 2014. Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes. Glycobiology. 24(6):518–531. doi: 10.1093/glycob/cwu020.
   PubMed Web of Science ®Google Scholar
• Morabito C, Rovetta F, Bizzarri M, Mazzoleni G, Fanò G, Mariggiò MA. 2010. Modulation of redox status and calcium handling by extremely low frequency electromagnetic fields in C2C12 muscle cells: a real-time, single-cell approach. Free Radic Biol Med. 48(4):579–589. doi: 10.1016/j.freeradbiomed.2009.12.005.
   PubMed Web of Science ®Google Scholar
• Oyama JI, Blais C, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T. 2004. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 109(6):784–789. doi: 10.1161/01.CIR.0000112575.66565.84.
   PubMed Web of Science ®Google Scholar
• Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. 2009. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex. Nature. 458(7242):1191–1195. doi: 10.1038/nature07830.
   PubMed Web of Science ®Google Scholar
• Proszynski TJ, Gingras J, Valdez G, Krzewski K, Sanes JR. 2009. Podosomes are present in a postsynaptic apparatus and participate in its maturation. Proc Natl Acad Sci USA. 106(43):18373–18378. doi: 10.1073/pnas.0910391106.
   PubMed Web of Science ®Google Scholar
• Rahiman SSF, Morgan M, Gray P, Shaw PN, Cabot PJ. 2017. Inhibitory effects of dynorphin 3-14 on the lipopolysaccharide-induced toll-like receptor 4 signalling pathway. Peptides. 90:48–54. doi: 10.1016/j.peptides.2017.02.004.
   PubMed Web of Science ®Google Scholar
• Ranneh Y, Akim AM, Hamid HA, Khazaai H, Fadel A, Zakaria ZA, Albujja M, Bakar MFA. 2021. Honey and its nutritional and anti-inflammatory value. BMC Complement Med Ther. 21(1):30. doi: 10.1186/s12906-020-03170-5.
   PubMedGoogle Scholar
• Seneviratne AN, Sivagurunathan B, Monaco C. 2012. Toll-like receptors and macrophage activation in atherosclerosis. Clin Chim Acta. 413(1–2):3–14. doi: 10.1016/j.cca.2011.08.021.
   PubMed Web of Science ®Google Scholar
• Sharifi-Rad M, Varoni EM, Salehi B, Sharifi-Rad J, Matthews KR, Ayatollahi SA, Kobarfard F, Ibrahim SA, Mnayer D, Zakaria ZA, et al. 2017. Plants of the genus Zingiber as a source of bioactive phytochemicals: from tradition to pharmacy. Molecules. 22(12):2145. doi: 10.3390/molecules22122145.
   PubMed Web of Science ®Google Scholar
• Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, Cheng G, Kupiec-Weglinski JW. 2005. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant. 5(8):1793–1800. doi: 10.1111/j.1600-6143.2005.00932.x.
   PubMed Web of Science ®Google Scholar
• Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ, Agnew ML, Hampton CR, Rothnie CL, Spring DJ, et al. 2006. Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation. 114(1_supplement):270. doi: 10.1161/CIRCULATIONAHA.105.000901.
   Google Scholar
• Sumitra M, Manikandan P, Kumar DA, Arutselvan N, Balakrishna K, Manohar BM, Puvanakrishnan R. 2001. Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem. 224(1–2):135–142. doi: 10.1023/a:1011927812753.
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. 2005. Toll-like receptors in innate immunity. Int Immunol. 17(1):1–14. doi: 10.1093/intimm/dxh186.
   PubMed Web of Science ®Google Scholar
• Wu HS, Zhang JX, Wang L, Tian Y, Wang H, Rotstein O. 2004. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int. 3:250–253.
   PubMedGoogle Scholar